← Leaderboards
James D Griffin
Dana-Farber Cancer Institute
$8,295,553
Attributed
$9,011,774
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$32,758,303 · 11
By mechanism
P01$30,142,099 · 9
R01$1,752,838 · 1
R37$863,366 · 1
Top collaborators
- Benjamin Levine Ebert5 shared
- Richard M Stone5 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Scott A Armstrong$21,470,003
- Kimberly Stegmaier$26,925,503
- Todd R. Golub$52,404,583
- Levi Alexander Garraway$17,056,330
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaMyeloid LeukemiaCellsProgramsResearch PersonnelNovel TherapeuticsOncogenesLaboratoriesSamplingIn VivoClinical TrialsIn VitroProteinsClinical ResearchPre-ClinicalMolecularTranscription FactorProtein Tyrosine KinaseMarrowBaseGrantPathway InteractionsFlt3 InhibitorMember
Grant awards (46)
Sample Processing and Analysis$268,386
P01 · FY2024 · CA · contact PI
Sample Processing and Analysis$282,401
P01 · FY2023 · CA · contact PI
Sample Processing and Analysis$276,783
P01 · FY2022 · CA · contact PI
Sample Processing and Analysis$282,433
P01 · FY2021 · CA · contact PI
Sample Processing and Analysis$288,935
P01 · FY2020 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,247,411
P01 · FY2018 · CA
Clinical Research Support Core$284,698
P01 · FY2018 · CA
Sample Processing and Analysis Core$270,962
P01 · FY2018 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,248,452
P01 · FY2017 · CA
Clinical Research Support Core$284,685
P01 · FY2017 · CA
Sample Processing and Analysis Core$270,948
P01 · FY2017 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,249,567
P01 · FY2016 · CA
Clinical Research Support Core$284,672
P01 · FY2016 · CA
Sample Processing and Analysis Core$270,933
P01 · FY2016 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,250,582
P01 · FY2015 · CA
Clinical Research Support Core$284,644
P01 · FY2015 · CA
Sample Processing and Analysis Core$270,902
P01 · FY2015 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,307,647
P01 · FY2014 · CA
Clinical Research Support Core$293,743
P01 · FY2014 · CA
Sample Processing and Analysis Core$280,536
P01 · FY2014 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,324,734
P01 · FY2012 · CA · contact PI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS$300,681
P01 · FY2012 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,306,268
P01 · FY2011 · CA · contact PI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS$298,834
P01 · FY2011 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,408,966
P01 · FY2010 · CA · contact PI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS$315,567
P01 · FY2010 · CA · contact PI
Development of Novel Therapeutic Strategies in Human Leukemias$2,367,210
P01 · FY2009 · CA · contact PI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS$311,047
P01 · FY2009 · CA · contact PI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS$302,258
P01 · FY2008 · CA · contact PI
Regulation of Hematopoiesis by Notch Receptors$337,486
R01 · FY2007 · CA · contact PI
Regulation of Hematopoiesis by Notch Receptors$347,565
R01 · FY2006 · CA · contact PI
Regulation of Hematopoiesis by Notch Receptors$355,929
R01 · FY2005 · CA
Regulation of Hematopoiesis by Notch Receptors$355,929
R01 · FY2004 · CA
Regulation of Hematopoiesis by Notch Receptors$355,929
R01 · FY2003 · CA
REGULATION OF MYELOPOIESIS$298,972
R37 · FY2002 · CA
ACTIVATION OF SIGNAL TRANSDUCTION PATHWAYS IN STABLE PHASE CHRONIC MYELOID$0
P01 · FY2002 · DK
CORE--FLOW CYTOMETRY$0
P01 · FY2002 · DK
TYROSINE KINASE ONCOGENESIS IN MYELOID LEUKEMIA$0
P01 · FY2002 · CA
NOVEL THERAPEUTIC STRATEGIES IN LEUKEMIA AND LYMPHOMA$932,947
P01 · FY2001 · CA
SIGNAL TRANSDUCTION PATHWAYS IN STABLE PHASE CHRONIC MYELOID LEUKEMIA CELLS$296,752
P01 · FY2001 · DK
REGULATION OF MYELOPOIESIS$286,296
R37 · FY2001 · CA
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA$0
P01 · FY2001 · CA
NOVEL THERAPEUTIC STRATEGIES IN LEUKEMIA AND LYMPHOMA$2,102,745
P01 · FY2000 · CA
REGULATION OF MYELOPOIESIS$278,098
R37 · FY2000 · CA
DEVELOPMENT OF IMMUNOTHERAPIES FOR CHRONIC MYELOID LEUKEMIA$226,134
P01 · FY2000 · CA
SIGNAL TRANSDUCTION PATHWAYS IN STABLE PHASE CHRONIC MYELOID LEUKEMIA CELLS$148,636
P01 · FY2000 · DK